Royal Melbourne Hospital
Royal Melbourne Hospital
Melbourne, Victoria, Australia7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM) | Acid-Base Imbalance, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, MELAS syndrome, Mitochondrial encephalopathy, Nutritional and Metabolic Diseases, acidosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, inborn mitochondrial metabolism disorder, inborn mitochondrial myopathy, lactic acidosis, metabolic disease, mitochondrial encephalomyopathy, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, vascular disorder | Active, not recruiting | Phase 2 | 2026-07-07 | NCT06961344 | |
| Study in Advanced Solid Tumor Patients | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-05-01 | NCT07300943 | |
| Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC) | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Inflammation, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Urogenital Diseases, breast disorder, breast neoplasm, endocrine system disorder, female reproductive system disorder, gonadal disorder, neoplasm, ovarian disorder, primary ovarian failure, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Not stated | 2026-04-14 | NCT07527819 | |
| Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Recruiting | Phase 3 | 2026-03-31 | NCT04939935 | |
| Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults | Bone Diseases, Metabolic, Critical Illness, Disease Attributes, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Recruiting | Phase 2 | 2026-03-04 | NCT04608630 | |
| Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer | Breast Neoplasm Female | Active, not recruiting | Phase 1 | 2024-11-07 | NCT03900884 | |
| AusCADASIL: An Australian Cohort of CADASIL | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, dementia, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2024-05-08 | NCT06148051 |